This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Academisch Ziekenhuis Groningen, Rijksuniversiteit Groningen. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 23 
1 out of 58 
Years Active: 2018
Title: Goffe Sytse Elsinga: Innovator in Immunology and Vaccine Development
Introduction
Goffe Sytse Elsinga is a notable inventor based in De Meern, Netherlands. He has made significant contributions to the field of immunology and vaccine development. His work primarily focuses on antibodies and their therapeutic and diagnostic applications.
Latest Patents
Goffe Sytse Elsinga holds a patent related to an isolated antibody or a functional fragment that binds to an epitope of the Immunodominant Staphylococcal antigen A (IsaA). This invention includes at least four IsaA epitope-binding CDR sequences selected from a specific group, with functional equivalents that maintain a high degree of amino acid sequence identity.
Career Highlights
Throughout his career, Goffe has worked with esteemed institutions such as Rijksuniversiteit Groningen and Academisch Ziekenhuis Groningen. His research has contributed to advancements in immunology, particularly in the development of vaccines.
Collaborations
Goffe has collaborated with notable colleagues, including Jan Maarten Van Dijl and Girbe Buist. These partnerships have enhanced his research and innovation efforts in the field.
Conclusion
Goffe Sytse Elsinga is a distinguished inventor whose work in immunology and vaccine development has the potential to impact therapeutic and diagnostic practices significantly. His contributions continue to advance the understanding and application of antibodies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile